Found: 13
Select item for more details and to access through your institution.
Utility of a Molecular Signature for Predicting Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer Patients: Comparison with the EORTC, CUETO and 2021 EAU Risk Groups.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 22, p. 14481, doi. 10.3390/ijms232214481
- By:
- Publication type:
- Article
Prognostic Value of BUB1 for Predicting Non-Muscle-Invasive Bladder Cancer Progression.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 23, p. 12756, doi. 10.3390/ijms222312756
- By:
- Publication type:
- Article
Role of Exosomal miRNA in Bladder Cancer: A Promising Liquid Biopsy Biomarker.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 4, p. 1713, doi. 10.3390/ijms22041713
- By:
- Publication type:
- Article
A Molecular Signature Determines the Prognostic and Therapeutic Subtype of Non-Muscle-Invasive Bladder Cancer Responsive to Intravesical Bacillus Calmette-Guérin Therapy.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 3, p. 1450, doi. 10.3390/ijms22031450
- By:
- Publication type:
- Article
Adventitious root cultures of Oplopanax elatus inhibit LPS-induced inflammation via suppressing MAPK and NF-κB signaling pathways.
- Published in:
- In Vitro Cellular & Developmental Biology Animal, 2019, v. 55, n. 9, p. 766, doi. 10.1007/s11626-019-00396-7
- By:
- Publication type:
- Article
A New Treatment Landscape for RCC: Association of the Human Microbiome with Improved Outcomes in RCC.
- Published in:
- Cancers, 2023, v. 15, n. 3, p. 935, doi. 10.3390/cancers15030935
- By:
- Publication type:
- Article
Integrative Transcriptome Profiling Reveals SKA3 as a Novel Prognostic Marker in Non-Muscle Invasive Bladder Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4673, doi. 10.3390/cancers13184673
- By:
- Publication type:
- Article
CYTOR drives prostate cancer progression via facilitating AR‐V7 generation and its oncogenic signalling.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 5, p. 1, doi. 10.1002/ctm2.1230
- By:
- Publication type:
- Article
Collagen type VI-α1 and 2 repress the proliferation, migration and invasion of bladder cancer cells.
- Published in:
- International Journal of Oncology, 2021, v. 59, n. 1, p. N.PAG, doi. 10.3892/ijo.2021.5217
- By:
- Publication type:
- Article
Urinary cell‐free microRNA biomarker could discriminate bladder cancer from benign hematuria.
- Published in:
- International Journal of Cancer, 2019, v. 144, n. 2, p. 380, doi. 10.1002/ijc.31849
- By:
- Publication type:
- Article
A novel tumor suppressing gene, ARHGAP9, is an independent prognostic biomarker for bladder cancer.
- Published in:
- Oncology Letters, 2020, v. 19, n. 1, p. 476, doi. 10.3892/ol.2019.11123
- By:
- Publication type:
- Article
Differential Urinary Microbiome and Its Metabolic Footprint in Bladder Cancer Patients Following BCG Treatment.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 20, p. 11157, doi. 10.3390/ijms252011157
- By:
- Publication type:
- Article
ZNF492 and GPR149 methylation patterns as prognostic markers for clear cell renal cell carcinoma: Array-based DNA methylation profiling.
- Published in:
- Oncology Reports, 2019, v. 42, n. 1, p. 453, doi. 10.3892/or.2019.7151
- By:
- Publication type:
- Article